Literature DB >> 4589853

Spackle and immunity functions of bacteriophage T4.

J B Cornett.   

Abstract

Cells of Escherichia coli B infected with the immunity-negative (imm2) mutant of bacteriophage T4 are able to develop a substantial level of immunity to superinfecting phage ghosts if the ghost challenge is made late in infection. This background immunity is not seen in infections with phage carrying the spackle (s) mutation in addition to the imm2 lesion. The level of immunity in s(-) infections is intermediate between that of imm(-) and wild-type infections under standard assay conditions. With respect to genetic exclusion of superinfecting phage, cells infected with imm(-) phage are completely deficient, whereas infections with the s(-) phage are only partially deficient compared to wild-type infections. Whereas s(-)-infected cells are unable to resist lysis from without by a high multiplicity of infection (MOI) of superinfecting phage, cells infected with imm(-) phage show less than wild-type levels of resistance and the majority of cells remaining intact are unable to incorporate leucine or form infective centers. Under conditions of superinfection by low MOI of homologous phage, imm(-)-infected cells are lysis inhibited, whereas s(-)-infected cells do not show this property. Superinfecting phage inject their DNA into imm(-)-infected cells with the same efficiency as seen in wild-type infections, but this efficiency is reduced when the cells are first infected with s(-) phage. The s function of T4 appears not only to affect the host cell wall as previously postulated by Emrich, but may also affect the junctures of cell wall and membrane with consequences similar to those of the imm function.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4589853      PMCID: PMC355299     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  Properties of phage T4 messenger RNA synthesized in the absence of protein synthesis.

Authors:  R F Peterson; P S Cohen; H L Ennis
Journal:  Virology       Date:  1972-04       Impact factor: 3.616

2.  Inhibition of host protein synthesis during infection of Escherichi coli by bacteriophage T4. 3. Inhibition by ghosts.

Authors:  R Fabricant; D Kennell
Journal:  J Virol       Date:  1970-12       Impact factor: 5.103

3.  The metabolism of T4 phage ghost-infected cells. I. Macromolecular synthesis and ransport of nucleic acid and protein precursors.

Authors:  D H Duckworth
Journal:  Virology       Date:  1970-03       Impact factor: 3.616

4.  Involvement of a phage T4 sigma factor and an anti-terminator protein in the transcription of early T4 genes in vivo.

Authors:  D A Schmidt; A J Mazaitis; T Kasai; E K Bautz
Journal:  Nature       Date:  1970-03-14       Impact factor: 49.962

5.  Replication of T4rII bacteriophage in Escherichia coli K-12 (lambda).

Authors:  C S Buller; L Astrachan
Journal:  J Virol       Date:  1968-04       Impact factor: 5.103

6.  Adsorption of bacteriophages to adhesions between wall and membrane of Escherichia coli.

Authors:  M E Bayer
Journal:  J Virol       Date:  1968-04       Impact factor: 5.103

7.  Inhibition of T4 bacteriophage multiplication by superinfecting ghosts and the development of tolerance after bacteriophage infection.

Authors:  D H Duckworth
Journal:  J Virol       Date:  1971-01       Impact factor: 5.103

8.  Studies on the physiological defect in rII mutants of bacteriophage T4.

Authors:  M Sekiguchi
Journal:  J Mol Biol       Date:  1966-04       Impact factor: 5.469

9.  Phospholipid synthesis in Escherichia coli infected with T4 bacteriophages.

Authors:  M H Furrow; L I Pizer
Journal:  J Virol       Date:  1968-06       Impact factor: 5.103

10.  A comparison of the number of nucleotides per unit length in Escherichia coli and phage T4 chromosomes.

Authors:  C Bernstein
Journal:  Biophys J       Date:  1970-12       Impact factor: 4.033

View more
  11 in total

Review 1.  Colicinogeny and related phenomena.

Authors:  K G Hardy
Journal:  Bacteriol Rev       Date:  1975-12

2.  Lysis of lysis-inhibited bacteriophage T4-infected cells.

Authors:  S T Abedon
Journal:  J Bacteriol       Date:  1992-12       Impact factor: 3.490

3.  Selection for bacteriophage latent period length by bacterial density: A theoretical examination.

Authors:  S T Abedon
Journal:  Microb Ecol       Date:  1989-09       Impact factor: 4.552

4.  Genetic response to bacteriophage infection in Lactococcus lactis reveals a four-strand approach involving induction of membrane stress proteins, D-alanylation of the cell wall, maintenance of proton motive force, and energy conservation.

Authors:  Vincenzo Fallico; R Paul Ross; Gerald F Fitzgerald; Olivia McAuliffe
Journal:  J Virol       Date:  2011-08-31       Impact factor: 5.103

5.  Crystal structure of bacteriophage T4 Spackle as determined by native SAD phasing.

Authors:  Ke Shi; Fredy Kurniawan; Surajit Banerjee; Nicholas H Moeller; Hideki Aihara
Journal:  Acta Crystallogr D Struct Biol       Date:  2020-08-25       Impact factor: 7.652

6.  Phospholipase activity in bacteriophage-infected Escherichia. II. Activation of phospholipase by T4 ghost infection.

Authors:  C S Buller
Journal:  J Virol       Date:  1975-05       Impact factor: 5.103

7.  Recovery of the accumulation ability of thiomethyl-beta-galactoside in Escherichia coli after bacteriophage T4 infection.

Authors:  N Saijo; K Okamoto
Journal:  J Virol       Date:  1976-02       Impact factor: 5.103

8.  The immunity (imm) gene of Escherichia coli bacteriophage T4.

Authors:  M J Lu; U Henning
Journal:  J Virol       Date:  1989-08       Impact factor: 5.103

9.  Bacteriophage T4 genes sp and 40 apparently are the same.

Authors:  J Obringer; P McCreary; H Bernstein
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

Review 10.  Look Who's Talking: T-Even Phage Lysis Inhibition, the Granddaddy of Virus-Virus Intercellular Communication Research.

Authors:  Stephen T Abedon
Journal:  Viruses       Date:  2019-10-16       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.